Clinical outcome after percutaneous endoscopic gastrostomy in children with malignancies

Deena M Parbhoo1, Karin Tiedemann, Anthony G Catto-Smith

  • 1Department of Gastroenterology and Clinical Nutrition, Victoria, Australia.

Insights

Percutaneous endoscopic gastrostomies (PEGs) are underutilized in pediatric oncology. This study found PEGs effectively reversed weight loss in children with cancer, with few complications leading to early removal.

Area of Science:

  • Pediatric Oncology
  • Gastroenterology
  • Surgical Procedures

Background:

  • Percutaneous endoscopic gastrostomy (PEG) is infrequently used in pediatric oncology patients.
  • Nutritional support is crucial for children undergoing cancer treatment.
  • Evaluating PEG safety and efficacy in this population is warranted.

Purpose of the Study:

  • To assess the complications and efficacy of PEG placement in pediatric oncology patients.
  • To determine the impact of PEG on nutritional status (weight gain).
  • To analyze the incidence of infectious complications and their effect on PEG retention.

Main Methods:

  • Retrospective case series analysis.
  • Inclusion of pediatric patients with malignancies requiring PEG insertion.
  • Outcome measures included wound infections and changes in weight-for-age z-scores.

Main Results:

  • Sixteen PEGs were placed in 14 pediatric patients (mean age 10.3 years).
  • Nine patients experienced 16 wound infections (3.7 episodes/1,000 days).
  • Mean weight-for-age z-score declined pre-PEG but stabilized post-placement (P < 0.001).
  • Two PEGs (12%) were removed early; infectious complications rarely necessitated early removal.

Conclusions:

  • PEG placement can effectively reverse weight loss in pediatric oncology patients.
  • While infections can occur, they typically do not lead to early PEG removal.
  • PEGs represent a viable option for nutritional support in this patient group.